ArticleEndocrine2022

Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma.

Sebastian E Serfling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.